The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 48 (23) , 2259-2265
- https://doi.org/10.1016/0024-3205(91)90341-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005
- Dependence of hydrogen peroxide formation in rat liver microsomes on the molecular structure of cytochrome P-450 substrates: A study with barbiturates and β-adrenoceptor antagonistsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1989
- Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure—Pharmacokinetic relationshipsJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Some Advantages of Calculating Octanol—Water Partition CoefficientsJournal of Pharmaceutical Sciences, 1987
- The Polymorphic Oxidation of ??-Adrenoceptor AntagonistsClinical Pharmacokinetics, 1986
- Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in manJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- The clinical importance of cardioselectivity and lipophilicity in beta blockersAmerican Heart Journal, 1980
- p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical StructureJournal of the American Chemical Society, 1964
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934